During the past decade, Southern Eye Specialists conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Southern Eye Specialists" #1 collaborator was "Novotech (Australia) Pty Limited" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Southern Eye Specialists" are "Geographic Atrophy" (2 trials), "Diabetic Macular Oedema" (1 trials), "Geographic Atrophy Secondary to Age-related Macular Degeneration" (1 trials) and "Retinal Vein Occlusion With Macular Oedema" (1 trials). Many other conditions were trialed in "Southern Eye Specialists" in a lesser frequency.

Most popular intervention types in "Southern Eye Specialists" are "Drug" (4 trials), "Other" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "APL-2" (1 trials), "IBE-814 140ug" (1 trials), "IBE-814 70ug" (1 trials), "ONL1204 Ophthalmic solution" (1 trials) and "PEGCETACOPLAN (APL-2)" (1 trials). Other intervention names were less common.

The vast majority of trials in "Southern Eye Specialists" are 4 trials for "All" genders.

Currently, there are NaN active trials in "Southern Eye Specialists". undefined are not yet recruiting, 1 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Southern Eye Specialists, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Southern Eye Specialists, 1 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".